Back to Results
First PageMeta Content
Combination drugs / Asthma / Epidemiology / Fluticasone/salmeterol / Zileuton / Omalizumab / Cromoglicic acid / Clinical trial / Pulmonology / Medicine / Respiratory therapy


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived
Add to Reading List

Open Document

File Size: 757,14 KB

Share Result on Facebook

Company

GlaxoSmithKline / M.D. / /

Country

United States / /

MedicalCondition

COPD / asthma / allergies Persistent Asthma / /

Organization

US Department of Health and Human Services / National Institute of Health / U.S. Food and Drug Administration / /

Person

Katharine Knobil / SABA PRN / Carlos Camargo / Respiratory Medicines / /

Position

Vice President / /

Product

Theophylline / /

URL

www.lungusa.org / http /

SocialTag